Cartesian Growth Corporation II
RENE
NASDAQ Global Market11.75
USD
- -
- -
CIK
0001889112
ISIN
KYG193051128
CUSIP
G19305112
Return %
Stock
S&P500
1Y
-1.43
26.84
3Y
12.01
77.03
5Y
18.03
80.55
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Peter Michael Yu
- Full Time Employees
- 2
- Sector
- Financial Services
- Industry
- Shell Companies
- Address
- 505 Fifth Avenue New York City NY United States of America 10017
- IPO Date
- Jul 8, 2022
- CIK
- 0001889112
- Website
- cartesiangrowth.com
- Similar Companies
- Business
- Cartesian Growth Corporation II (RENE) is a blank check company sponsored by an affiliate of Cartesian Capital Group LLC that seeks to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more high-growth businesses. Incorporated in the Cayman Islands in October 2021 and headquartered at 505 Fifth Avenue, 15th Floor, New York, New York, the company has no significant current operations and holds cash in trust for deployment in a de-SPAC transaction; its securities, including Class A ordinary shares (RENE), units (RENEU), and warrants (RENEW), trade on Nasdaq. It targets established companies that can leverage public markets access, growth capital, and expertise from its management team led by CEO Peter Yu. The company offers public market readiness through its SPAC structure, providing merger partners with liquidity, financing solutions, and strategic advisory from its board and sponsors; it focuses on sectors suitable for high-growth entities without predefined industry restrictions. Geographically, Cartesian Growth Corporation II operates primarily from the United States with a focus on global opportunities for targets benefiting from U.S. capital markets. In recent developments, the company entered a non-binding Letter of Framework on October 16, 2025, to acquire Plxsur Limited for a nominal amount, subject to board and shareholder approvals, antitrust clearances, regulatory consents, and other closing conditions; upon completion, Plxsur would merge into Cartesian, ceasing its separate existence. Advisors included Greenberg Traurig for Cartesian and White & Case for Plxsur, with Cantor Fitzgerald and Piper Sandler as brokers. It has extended its business combination deadline multiple times, most recently to February 2025, and filed quarterly reports through Q3 2025 showing trust earnings but no revenue.